
STAAR Surgical Company STAA
$ 23.09
-0.52%
Quarterly report 2025-Q3
added 11-05-2025
STAAR Surgical Company Interest Expense 2011-2026 | STAA
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense STAAR Surgical Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 815 K | 448 K | 205 K | -48 K | 152 K | - | 82 K | 112 K | 115 K | 154 K | 170 K | - | 291 K | 523 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 815 K | -48 K | 252 K |
Quarterly Interest Expense STAAR Surgical Company
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 353 K | 120 K | 131 K | - | 139 K | 63 K | 330 K | - | 71 K | 10 K | 63 K | - | 27 K | 89 K | 62 K | - | -13 K | 51 K | -85 K | - | -63 K | -21 K | 1 K | - | 26 K | 1 K | 97 K | - | 40 K | 4 K | 17 K | - | 27 K | 32 K | 28 K | - | 29 K | 29 K | 28 K | - | 29 K | 33 K | 36 K | - | 35 K | 34 K | 33 K | - | 38 K | 41 K | 83 K | - | 65 K | 67 K | 95 K | - | 134 K | 153 K | 153 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 353 K | -85 K | 60.3 K |
Interest Expense of other stocks in the Medical instruments industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Baxter International
BAX
|
408 M | $ 19.11 | -0.98 % | $ 9.75 B | ||
|
Becton, Dickinson and Company
BDX
|
613 M | $ 194.07 | -0.8 % | $ 55.8 B | ||
|
Ekso Bionics Holdings
EKSO
|
-1 K | $ 8.64 | -18.34 % | $ 174 M | ||
|
Harvard Bioscience
HBIO
|
-227 K | $ 0.67 | 1.66 % | $ 28.4 M | ||
|
Repro Med Systems
KRMD
|
561 K | $ 5.81 | 2.11 % | $ 265 M | ||
|
Alcon
ALC
|
192 M | $ 78.81 | -0.64 % | $ 40.4 B | ||
|
AtriCure
ATRC
|
-326 K | $ 39.56 | -1.54 % | $ 1.86 B | ||
|
Atrion Corporation
ATRI
|
149 | - | - | $ 810 M | ||
|
ICU Medical
ICUI
|
107 M | $ 142.67 | -1.36 % | $ 3.48 B | ||
|
electroCore
ECOR
|
6.3 M | $ 4.49 | -3.55 % | $ 24.8 K | ||
|
iRhythm Technologies
IRTC
|
1.25 M | $ 177.44 | -0.63 % | $ 5.54 B | ||
|
AngioDynamics
ANGO
|
4.94 M | $ 12.84 | -1.23 % | $ 525 M | ||
|
Isoray
ISR
|
2 K | - | 0.03 % | $ 108 M | ||
|
The Cooper Companies
COO
|
-16.4 M | $ 81.96 | -0.62 % | $ 16.3 B | ||
|
Glaukos Corporation
GKOS
|
13.6 M | $ 112.91 | -1.16 % | $ 5.47 B | ||
|
LeMaitre Vascular
LMAT
|
205 K | $ 81.1 | -2.3 % | $ 1.82 B | ||
|
Haemonetics Corporation
HAE
|
-9.75 M | $ 80.15 | -1.02 % | $ 4.03 B | ||
|
InfuSystem Holdings
INFU
|
1.4 M | $ 8.97 | 0.67 % | $ 185 M | ||
|
Masimo Corporation
MASI
|
300 K | $ 130.06 | -0.77 % | $ 6.93 B | ||
|
OraSure Technologies
OSUR
|
-380 K | $ 2.42 | -2.02 % | $ 180 M | ||
|
Merit Medical Systems
MMSI
|
-711 K | $ 88.14 | -0.47 % | $ 5.13 B | ||
|
Microbot Medical
MBOT
|
2 K | $ 2.0 | -2.44 % | $ 20.4 M | ||
|
Milestone Scientific
MLSS
|
60.3 K | $ 0.27 | -0.22 % | $ 21.5 M | ||
|
Nephros
NEPH
|
2 K | $ 4.88 | 3.39 % | $ 50.7 M | ||
|
Stereotaxis
STXS
|
1.1 M | $ 2.3 | -0.22 % | $ 186 M | ||
|
Envista Holdings Corporation
NVST
|
-100 K | $ 21.71 | -0.91 % | $ 3.74 B | ||
|
STERIS plc
STE
|
8.4 M | $ 253.52 | -0.76 % | $ 25 B | ||
|
Pro-Dex
PDEX
|
533 K | $ 38.48 | -0.3 % | $ 127 M | ||
|
Predictive Oncology
POAI
|
3 | - | - | $ 32.4 M | ||
|
Utah Medical Products
UTMD
|
256 K | $ 55.96 | -0.57 % | $ 203 M | ||
|
Pulse Biosciences
PLSE
|
983 K | $ 13.73 | 0.22 % | $ 660 M | ||
|
ResMed
RMD
|
3.2 M | $ 240.87 | -0.91 % | $ 35.2 B | ||
|
DENTSPLY SIRONA
XRAY
|
12 M | $ 11.43 | 0.35 % | $ 2.32 B | ||
|
Repligen Corporation
RGEN
|
8.12 M | $ 163.86 | -1.64 % | $ 9.13 M | ||
|
BioLife Solutions
BLFS
|
497 K | $ 24.18 | -1.95 % | $ 1.11 B | ||
|
Retractable Technologies
RVP
|
227 K | $ 0.77 | -0.63 % | $ 23.1 M | ||
|
Teleflex Incorporated
TFX
|
57 M | $ 122.04 | 0.35 % | $ 5.72 B | ||
|
West Pharmaceutical Services
WST
|
-1 M | $ 275.14 | -0.62 % | $ 20.1 B |